Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Left motor cortex rTMS effects on brain connectivity

Official title: Effects of Left Primary Motor Cortex rTMS on Cortical Connectivity Assessed With TMS-EEG Across Left M1, Right M1, Premotor, and Occipital Cortices

Run by Aalborg University · NCT07580989 · Data updated 2026-11-12

This will test whether one session of rTMS to the left motor cortex changes EEG-measured brain connectivity in healthy adult volunteers.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment20 (estimated)
SponsorAalborg University
Academic / other
Locations1 site (Gistrup)
StatusRecruiting
StartedMay 1, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedMay 14, 2026
Trial IDNCT07580989 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are healthy adults who speak English, can consent and cooperate with procedures, and have no history of neurological, psychiatric, chronic pain, or contraindications to rTMS.

Probably not a fit

People with current or past neurological or psychiatric disorders, chronic or acute pain, substance use, or contraindications to TMS (for example epilepsy or metal in the head/jaw) are not likely to benefit and are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Healthy volunteers will receive a single session of repetitive transcranial magnetic stimulation (rTMS) over the left primary motor cortex with TMS-EEG recordings taken before and after stimulation. TMS pulses will be applied to four cortical targets—the left and right primary motor cortices, left premotor cortex, and right occipital cortex—to record TMS-evoked potentials (TEPs) that reflect cortical reactivity and connectivity. Pre- versus post-rTMS comparisons of TEPs will be used to map changes in network responses and determine whether one rTMS session alters large-scale cortical interactions. Participants will be screened for safety and excluded for neurological, psychiatric, chronic pain, or substance-use contraindications.

Why it matters

Potential benefit: If successful, the results could clarify how rTMS changes brain network activity and help refine stimulation targets or protocols for treating neurological and psychiatric conditions.

How similar studies have gone: Previous TMS-EEG and rTMS studies have demonstrated modulation of cortical responses after stimulation, but findings are variable and the mechanisms of network-level changes remain incompletely established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy men and women
* Speak and understand English

Exclusion Criteria:

* Drug addiction defined as the use of cannabis, opioids or other drugs
* Previous neurologic, musculoskeletal or mental illnesses
* Lack of ability to cooperate
* History of chronic pain or current acute pain
* Contraindications to rTMS application (history of epilepsy, metal in the head or jaw etc.).
* Failure to pass the "TASS questionnaire" (TASS = Transcranial Magnetic Stimulation Adult Safety Screen)

Where it's running

  • Aalborg University
    Gistrup, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.